Eltrombopag for Thrombocytopenia in Patients With Relapsed Multiple Myeloma
Clinical trial NCT01484314 · TERMINATED
Trial details
- NCT number
- NCT01484314
- Sponsor
- Dana-Farber Cancer Institute
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-04-01
- Primary completion
- 2014-09-01
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.